Financhill
Sell
28

OMRNF Quote, Financials, Valuation and Earnings

Last price:
$29.50
Seasonality move :
-9.15%
Day range:
$29.50 - $29.50
52-week range:
$24.76 - $34.87
Dividend yield:
2.37%
P/E ratio:
30.43x
P/S ratio:
1.06x
P/B ratio:
1.10x
Volume:
--
Avg. volume:
116
1-year change:
-3.97%
Market cap:
$5.8B
Revenue:
$5.3B
EPS (TTM):
$0.97

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, OMRON Corp. has -- downside to fair value with a price target of -- per share.

OMRNF vs. S&P 500

  • Over the past 5 trading days, OMRON Corp. has underperformed the S&P 500 by -0.31% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • OMRON Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • OMRON Corp. has grown year-over-year revenues for 3 quarters straight. In the most recent quarter OMRON Corp. reported revenues of $1.4B.

Earnings Growth

  • OMRON Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter OMRON Corp. reported earnings per share of $0.08.
Enterprise value:
7.2B
EV / Invested capital:
0.93x
Price / LTM sales:
1.06x
EV / EBIT:
20.71x
EV / Revenue:
1.32x
PEG ratio (5yr expected):
--
EV / Free cash flow:
108.07x
Price / Operating cash flow:
86.71x
Enterprise value / EBITDA:
12.66x
Gross Profit (TTM):
$2.4B
Return On Assets:
1.96%
Net Income Margin (TTM):
3.3%
Return On Equity:
2.86%
Return On Invested Capital:
2.36%
Operating Margin:
5.56%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $6.3B $5.3B $5.5B $1.3B $1.4B
Gross Profit $2.8B $2.3B $2.4B $579.8M $606.4M
Operating Income $579M $219M $349.5M $86.8M $76.9M
EBITDA $776.5M $443.9M $571.6M $143M $133.1M
Diluted EPS $1.94 -$0.03 $0.97 $0.21 $0.08
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $4.9B $3.4B $3.3B $3.7B $3.8B
Total Assets $7.6B $6.7B $6.8B $9.4B $9.5B
Current Liabilities $1.4B $1.4B $1.3B $1.7B $1.8B
Total Liabilities $1.9B $1.7B $1.7B $2.9B $3.1B
Total Equity $5.7B $5B $5.1B $6.5B $6.4B
Total Debt $330.6M $197M $211.3M $1B $1.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $440M $287.3M $396M $122.8M $99.2M
Cash From Investing -$339.6M -$790.6M -$301.2M -$108.5M -$74.7M
Cash From Financing -$254.3M $806.7M -$101.9M $36.6M -$5.5M
Free Cash Flow $105.5M -$37.5M $67M $45.3M $19.9M
OMRNF
Sector
Market Cap
$5.8B
$53.7M
Price % of 52-Week High
84.59%
58.3%
Dividend Yield
2.37%
0%
Shareholder Yield
1.96%
0.01%
1-Year Price Total Return
-3.97%
-11.32%
Beta (5-Year)
0.543
0.668
Dividend yield:
2.37%
Annualized payout:
$0.71
Payout ratio:
458.53%
Growth streak:
1 years

Technicals

8-day SMA
Sell
Level $29.50
200-day SMA
Buy
Level $27.91
Bollinger Bands (100)
Buy
Level 25.79 - 28.95
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $29.50
Relative Strength Index (RSI14)
Buy
Level 99.10
ADX Line
Buy
Level 98.42
Williams %R
Sell
Level 0
50-day SMA
Buy
Level $28.52
MACD (12, 26)
Buy
Level 0.24
25-day Aroon Oscillator
Sell
Level 0
On Balance Volume
Neutral
Level 865

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.7507)
Buy
CA Score (Annual)
Level (0.2787)
Buy
Beneish M-Score (Annual)
Level (-2.6358)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-2.0928)
Buy
Piotroski F Score (Annual)
Level (6)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

OMRON Corp. engages in the manufacture and sale of automation components, equipment, and systems. It operates through the following segments: Industrial Automation; Electronic and Mechanical Components; Automotive Electronic Components; Social Systems, Solutions, and Services; Healthcare; and Others. The Industrial Automation segment manufactures and sells control components and equipment for factory automation and production machinery. The Electronic and Mechanical Components segment produces and merchandises relays, switches, components, and units for amusement devices, connectors, and combination jogs. The Automotive Electronic Components segment supplies onboard electronic components aimed at auto makers and automotive component makers. The Social Systems, Solutions, and Services segment ideals with railway infrastructure, traffic control, road management, security, environmental solutions, and payment systems. The Healthcare segment sells digital blood pressure monitors, digital thermometers, body composition monitors, pedometers, biological information monitors, and nebulizers. The Others segment includes solar power generation systems, sensors, and liquid crystal display backlights. The company was founded by Kazuma Tateisi on May 10, 1933 and is headquartered in Kyoto, Japan.

Stock Forecast FAQ

In the current month, OMRNF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OMRNF average analyst price target in the past 3 months is --.

  • Where Will OMRON Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that OMRON Corp. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About OMRON Corp.?

    Analysts are divided on their view about OMRON Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that OMRON Corp. is a Sell and believe this share price will rise from its current level to --.

  • What Is OMRON Corp.'s Price Target?

    The price target for OMRON Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is OMRNF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for OMRON Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of OMRNF?

    You can purchase shares of OMRON Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase OMRON Corp. shares.

  • What Is The OMRON Corp. Share Price Today?

    OMRON Corp. was last trading at $29.50 per share. This represents the most recent stock quote for OMRON Corp.. Yesterday, OMRON Corp. closed at $29.50 per share.

  • How To Buy OMRON Corp. Stock Online?

    In order to purchase OMRON Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock